Nureca (NURECA) — Annual Report

Nureca Limited's FY26 annual report shows revenue growth of 34% to ₹1,469.93 crores, EBITDA up 68.94% to [amount context mismatch] crores, and PAT surging 146.10% to [amount context mismatch] crores, driven by strong domestic demand and operational improvements. The company appointed Ms. Smita Goyal as Whole-time Director effective June 1, 2026, while CEO Mr. Aryan Goyal will resign on July 1, 2026. Board composition remains stable with 5 independent directors out of 8 total, and the merger with Nureca Technologies is shareholder-approved. Key risks include foreign exchange volatility, regulatory changes, and intense competition in India's healthcare market, though the company maintains a healthy current ratio of 25 and ROCE of 521%.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NURECA ✨ Ask AI About This

About Nureca Limited (NURECA)

Consumer Services · E-Commerce/App based Aggregator · Listed on NSE

Market Cap: ₹319.37 Cr P/E: 77.8 ROE: 2.4% ROCE: 5.2%

View full NURECA stock details →

📡 Get AI alerts when NURECA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NURECA — Free

💡 Ask AI about this filing

"How does this annual report affect Nureca Limited's outlook?" "What did Nureca Limited announce on 3 July 2026?" "Is this positive or negative for NURECA?"

Ask AI Free →

📊 More NURECA filings

See all NURECA filings →

🔥 Also filed on 3 July 2026

PRESTIGE Prestige Estates Projects Limited Announcement PROZONER Prozone Realty Limited Announcement PRUDENT Prudent Corporate Advisory Services Limited Annual Report PTL PTL Enterprises Limited Annual Report RADIOCITY Music Broadcast Limited Announcement RBLBANK RBL Bank Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NURECA files new disclosures

Track NURECA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NURECA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd